hotspot -WSS

hotspot

author：hotspot 2025-09-03 12:01:43 - browse：29472

Seng Cheng has been working in gene therapy for nearly as long as gene therapy has been a field. As a young scientist in the early 1990s, he was part of one of three teams racing to develop a gene therapy for cystic fibrosis, a high-profile effort that resulted in national headlines, prestigious publications, and zero patients cured.

So he’s seen the field’s highs and lows. Lately, there have been a lot of both, including at Pfizer, the company Cheng called home until this summer. The pharma brought three potentially powerful gene therapies for muscular dystrophy and hemophilia into late-stage trials but, in January, chose to abandon a large portfolio of early stage candidates that relied on the same technology: adeno-associated viruses, or AAVs, a group of small bugs that scientists spent two decades taming into a gene shipping system.

The move seemed emblematic. Across the industry, AAV companies have been struggling, either shelving programs or stopping work altogether, while investors shuttled money toward new technologies such as CRISPR and its various permutations. Longtime researchers feared promising drugs, particularly for ultra-rare diseases, might get lost in the shuffle.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： NYU Langone launches private ChatGPT for its health care data

Wikipedia

WSS

CDC recommends RSV monoclonal antibody for infants

Chris Christie meets with Zelenskyy during Ukraine trip

It costs an awful lot of money to give away a kidney

What AAP's gender

2024 GOP presidential candidates spar over abortion in debate

The a glaring gap in research on serious mental illness and primary care

knowledge

hotspot

entertainment

What does generative AI mean for health care? We asked experts

FDA approves Sage Therapeutics’ rapid

New air purifier tech could be key to improving indoor air quality

Departing Stanford president retracts two papers

Medical leaders decry Supreme Court decision on affirmative action

Late stage cancers on the rise after pandemic delayed screenings

Anesthesiologist group: stop taking Ozempic before surgery

Radiation, mainstay of cancer treatment, begins a fade

Novavax promises a turnaround & Lilly roils the obesity market

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

knowledge

Radiation, mainstay of cancer treatment, begins a fade

Diversity in medical illustrations gets boost from Chidiebere Ibe

Medicare explains how it will choose drugs for negotiation

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Personalized medicine goes far beyond genetics

Radiation, mainstay of cancer treatment, begins a fade

Wikipedia

entertainment

focus

focus